Ruthenium half-sandwich complexes as protein kinase inhibitors: an N-succinimidyl ester for rapid derivatizations of the cyclopentadienyl moiety.
about
PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancersStructure-Based Design of an Organoruthenium Phosphatidyl-inositol-3-kinase Inhibitor Reveals a Switch Governing Lipid Kinase Potency and SelectivityExtremely Tight Binding of a Ruthenium Complex to Glycogen Synthase Kinase 3Targeting Pim kinases for cancer treatment: opportunities and challengesThe PIM kinases in hematological cancersPIM1 kinase as a target for cancer therapyEnzyme microarrays assembled by acoustic dispensing technology.Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases.Development of organometallic S6K1 inhibitors.Selective and potent small-molecule inhibitors of PI3Ks.A flexible-protein molecular docking study of the binding of ruthenium complex compounds to PIM1, GSK-3β, and CDK2/Cyclin A protein kinases.From imide to lactam metallo-pyridocarbazoles: distinct scaffolds for the design of selective protein kinase inhibitors.Marine pyrrolocarbazoles and analogues: synthesis and kinase inhibition.Why target PIM1 for cancer diagnosis and treatment?Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds.The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cellsMetallo-nucleosides: synthesis and biological evaluation of hexacarbonyl dicobalt 5-alkynyl-2'-deoxyuridines.Toward the development of a potent and selective organoruthenium mammalian sterile 20 kinase inhibitor.New organometallic imines of rhenium(i) as potential ligands of GSK-3β: synthesis, characterization and biological studies.Metal Compounds as Kinase and Phosphatase Inhibitors in Drug Development: The Role of the Metal and LigandsAnticancer Activities of Mononuclear Ruthenium(II) Coordination Complexes
P2860
Q24603099-49FAF1D8-4680-4DA6-983F-AB0C90351F15Q27650628-DD49E157-FDE9-489F-A9CA-FA26C7D92170Q27652994-2742C79C-47A6-4D34-89BA-53E531C719BAQ28255361-56301C2C-7A45-4252-8B67-D4633DE71EF0Q28258028-A8EA8A24-490C-4BE7-A979-EDBE1A5318A9Q28261162-ADB9EE27-5E3C-46C3-804F-9A085057F2EBQ30486231-2C35A0B3-2EC8-4BA0-AB78-ADC5A695C918Q33603053-29FD6131-E160-4DA7-A86E-A3C2CE76A636Q34891733-C5B993BF-AF1F-4A84-A6CA-7CCBFD61E01EQ35190512-9271612D-B93C-48B9-81C5-88EADBEFDC83Q36511074-E56F41D7-367F-4908-951C-2FAC26189807Q37457019-F0ED874E-8621-4E88-B60F-AB61DD6EDBE5Q37680686-829DBA88-7555-4260-94CC-80658DAC5177Q37797472-FA68A47A-1F84-4E34-BF50-E475FEEF35B0Q38776872-54320753-692F-43B0-AFC7-A7233B817060Q39400527-458825B2-9A27-41AC-A64D-F944864679E5Q39840520-9AA58FF3-7D87-43F6-9943-3EC9BC0F08D0Q40036405-7835EE35-C6B6-42B8-AEC2-8142C8F2349CQ43097841-992CD6EC-80C8-43A4-893D-FFAE359AFC07Q47233654-A5CF2A7B-E877-40D0-8E4D-69D892ECEA18Q57693525-3BDD2401-8CDA-442D-960A-843726233392Q59101621-D98EECFC-ACA5-4E1D-9B3B-2D39E185E65E
P2860
Ruthenium half-sandwich complexes as protein kinase inhibitors: an N-succinimidyl ester for rapid derivatizations of the cyclopentadienyl moiety.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Ruthenium half-sandwich comple ...... f the cyclopentadienyl moiety.
@ast
Ruthenium half-sandwich comple ...... f the cyclopentadienyl moiety.
@en
Ruthenium half-sandwich comple ...... f the cyclopentadienyl moiety.
@nl
type
label
Ruthenium half-sandwich comple ...... f the cyclopentadienyl moiety.
@ast
Ruthenium half-sandwich comple ...... f the cyclopentadienyl moiety.
@en
Ruthenium half-sandwich comple ...... f the cyclopentadienyl moiety.
@nl
prefLabel
Ruthenium half-sandwich comple ...... f the cyclopentadienyl moiety.
@ast
Ruthenium half-sandwich comple ...... f the cyclopentadienyl moiety.
@en
Ruthenium half-sandwich comple ...... f the cyclopentadienyl moiety.
@nl
P356
P1433
P1476
Ruthenium half-sandwich comple ...... f the cyclopentadienyl moiety.
@en
P2093
Howard Bregman
P304
P356
10.1021/OL0620646
P407
P50
P577
2006-11-01T00:00:00Z